As Accenture (ACN) gears up to release its Fiscal Q4 results on September 26, I view its shares as offering a compelling investment opportunity. The company’s solid Fiscal Q3 results, driven by growth ...
Accenture's GenAI pivot is gaining traction, with $5.1B in bookings, but still only 4% of total revenues—progress, but not yet transformative. Q3 earnings and revenue beat expectations, yet bookings ...
Accenture plc (NYSE: ACN) heads into Thursday’s earnings with its share price down roughly 22% this year, as slowing contract momentum and macro uncertainty have overshadowed what management pitches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results